Trial Outcomes & Findings for Impact of Early Enteral vs. Parenteral Nutrition on Mortality in Patients Requiring Mechanical Ventilation and Catecholamines (NCT NCT01802099)
NCT ID: NCT01802099
Last Updated: 2026-04-16
Results Overview
COMPLETED
NA
2410 participants
28 days
2026-04-16
Participant Flow
Participant milestones
| Measure |
Parenteral Nutrition
Patients will receive parenteral nutrition during the first week of mechanical ventilation. After Day 3, the parenteral route may be switched to the enteral route if shock resolve (vasoactive drug stopped since 24 hours and serum lactate level \< 2 mmol/l). After Day 7, all patients will be fed via the enteral route.
Parenteral nutrition
|
Enteral Nutrition
Patients will receive nutrition only via the enteral route during the firs week of invasive mechanical ventilation.
Enteral nutrition
|
|---|---|---|
|
Overall Study
STARTED
|
1208
|
1202
|
|
Overall Study
COMPLETED
|
1208
|
1202
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Parenteral Nutrition
n=1208 Participants
Patients will receive parenteral nutrition during the first week of mechanical ventilation. After Day 3, the parenteral route may be switched to the enteral route if shock resolve (vasoactive drug stopped since 24 hours and serum lactate level \< 2 mmol/l). After Day 7, all patients will be fed via the enteral route.
Parenteral nutrition
|
Enteral Nutrition
n=1202 Participants
Patients will receive nutrition only via the enteral route during the firs week of invasive mechanical ventilation.
Enteral nutrition
|
Total
n=2410 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
66 years
STANDARD_DEVIATION 14 • n=1208 Participants
|
66 years
STANDARD_DEVIATION 14 • n=1202 Participants
|
66 years
STANDARD_DEVIATION 14 • n=2410 Participants
|
|
Sex: Female, Male
Female
|
815 Participants
n=1208 Participants
|
809 Participants
n=1202 Participants
|
1624 Participants
n=2410 Participants
|
|
Sex: Female, Male
Male
|
393 Participants
n=1208 Participants
|
393 Participants
n=1202 Participants
|
786 Participants
n=2410 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
France
|
1208 participants
n=1208 Participants
|
1202 participants
n=1202 Participants
|
2410 participants
n=2410 Participants
|
PRIMARY outcome
Timeframe: 28 daysOutcome measures
| Measure |
Parenteral Nutrition
n=1208 Participants
Patients will receive parenteral nutrition during the first week of mechanical ventilation. After Day 3, the parenteral route may be switched to the enteral route if shock resolve (vasoactive drug stopped since 24 hours and serum lactate level \< 2 mmol/l). After Day 7, all patients will be fed via the enteral route.
Parenteral nutrition
|
Enteral Nutrition
n=1202 Participants
Patients will receive nutrition only via the enteral route during the firs week of invasive mechanical ventilation.
Enteral nutrition
|
|---|---|---|
|
Mortality
|
422 Participants
|
443 Participants
|
SECONDARY outcome
Timeframe: 90 daysPopulation: Patient dead at day 28 are not analysed
Outcome measures
| Measure |
Parenteral Nutrition
n=1192 Participants
Patients will receive parenteral nutrition during the first week of mechanical ventilation. After Day 3, the parenteral route may be switched to the enteral route if shock resolve (vasoactive drug stopped since 24 hours and serum lactate level \< 2 mmol/l). After Day 7, all patients will be fed via the enteral route.
Parenteral nutrition
|
Enteral Nutrition
n=1185 Participants
Patients will receive nutrition only via the enteral route during the firs week of invasive mechanical ventilation.
Enteral nutrition
|
|---|---|---|
|
Mortality Rate
|
507 Participants
|
530 Participants
|
SECONDARY outcome
Timeframe: until weaning of mechanical ventilation (average: 7 days)Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: until discharge from ICU (average: 10 days)Bloodstream infection Urinary tract infection Catheter-related infection Other infections
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: until discharge from ICU (average: 10 days)Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: until discharge from hospital (average: 17 days)Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: first week (7 days) of mechanical ventilationOutcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: until weaning of mechanical ventilation (average : 7 days)Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: until weaning of mechanical ventilation (average: 7 days)Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: During the first week (7 days) of mechanical ventilationOutcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Until discharge from hospital (average : 17 days)Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: until discharge from ICU (average: 10 days)Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: until weaning of mechanical ventilation (average: 7 days)Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: until weaning of mechanical ventilation (average: 7 days)Outcome measures
Outcome data not reported
Adverse Events
Parenteral Nutrition
Enteral Nutrition
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place